Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
By targeting both glucagon-like peptide-1 and glucose-dependent insulinotropic peptide receptors, tirzepatide reduces hunger signals, slows gastric emptying, and improves insulin sensitivitymechanisms supported by Phase 3 SURMOUNT clinical trials showing 22.5% weight reduction over 68 weeks
Real science doesnt need hyperbole
The 2024 Zaki split-face trial in International Journal of Dermatology demonstrated significantly better outcomes at 2.5mm versus 1.5mm for atrophic scars [36]
As the elderly population is highly prone to health issues such as Type 2 diabetes, the growing geriatric population is expected to drive the GLP-1 analogues market during the forecast period
US$ 26.21
US$ 28.41
US$ 25.86
US$ 22.07
